Condition: Sarcoma · Malignant Mesenchymoma · Sarcoma of Bone and Connective Tissue · Sponsor: Prof. Dr. Richard F Schlenk
SarcBOP - An interdisciplinary and translational registry SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.
This description comes directly from the study's public registry record.
Richard F. Schlenk, Prof.Dr.med · +49 6221 56 6228 · richard.schlenk@med.uni-heidelberg.de
SarcBOP Team · sarcbop@nct-heidelberg.de
Always discuss trial participation with your own doctor first.
| National Center for Tumour Diseases, University Hospital Heidelberg | Heidelberg, Baden-Wurttemberg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04758325